Community
Talking with a client recently they gave me an interesting perspective on the new OTC derivatives regulations that will be hitting the markets. Their question was – comply, protect or grow?
Dodd-Frank and EMIR will be radically re-shaping the OTC derivatives marketplace by the end of 2012. The Tabb Group in a recent report predict that transaction volumes could increase 20 times and market data 4 times with a shift away from exotic to vanilla products. It gives banks three potential routes:
The new world is likely to be characterised by fierce competition for standardised products where scale, operational efficiency and cost per trade are going to be the key principles so the “grow” option is going to require significant investment in processes and technology. From our contacts in the market we can see that there are leading players out there who have realised this and are making those investments. This could lead to a major shake out in the wholesale banking landscape.
So what do you think banks are going to do? comply, protect or grow?
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.
Ritesh Jain Founder at Infynit / Former COO HSBC
05 February
Harish Maiya CEO at Orin
03 February
Hirander Misra Chairman and CEO at GMEX Group
Alex Kreger Founder & CEO at UXDA
Welcome to Finextra. We use cookies to help us to deliver our services. You may change your preferences at our Cookie Centre.
Please read our Privacy Policy.